Canada signs agreements for 1.5M courses of Pfizer, Merck COVID-19 antiviral pills

Public Services and Procurement Minister Filomena Tassi announced Friday that pending Health Canada authorization, Canada has signed agreements for one million doses of the Pfizer COVID-19 anti-viral pill and 500,000 courses of the Merck anti-viral pill, with the option to secure up to 500,000 more.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting